| Drug Name |
Lomefloxacin |
| Drug ID |
BADD_D01309 |
| Description |
Lomefloxacin is a fluoroquinolone antibiotic, used to treat bacterial infections including bronchitis and urinary tract infections (UTIs). Additionally, it has been employed for the prophylaxis of UTIs prior to surgery as well. |
| Indications and Usage |
For the treatment of bacterial infections of the respiratory tract (chronic bronchitis) and urinary tract, and as a pre-operative prophylactic to prevent urinary tract infection caused by: S.pneumoniae, H.influenzae, S.aureus, P.aeruginosa, E. cloacae, P. mirabilis, C. civersus, S. asprphyticus, E.coli, and K.pneumoniae. |
| Marketing Status |
approved; investigational |
| ATC Code |
J01MA07; S01AE04 |
| DrugBank ID |
DB00978
|
| KEGG ID |
D02318
|
| MeSH ID |
C053091
|
| PubChem ID |
3948
|
| TTD Drug ID |
D02KOF
|
| NDC Product Code |
Not Available |
| UNII |
L6BR2WJD8V
|
| Synonyms |
lomefloxacin | lomenfloxacin | 1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid | lomefloxacin hydrochloride | Maxaquin | Logiflox | Ocacin | Okacin | Okacyn | SC 4711 | SC-4711 | Décalogiflox | NY 198 | NY-198 |
